Medication info
Valdipin Plus Tablet 5/80/12.5 mg (Amlodipine, Valsartan, Chlorthalidone)

Valdipin Plus Tablet 5/80/12.5 mg (Amlodipine, Valsartan, Chlorthalidone)

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.935mg / 1 tabletValsartan›80mg / 1 tabletChlorthalidone›12.5mg / 1 tablet
Manufacturer / importer
Kyung Dong Pharm Co., Ltd.
Appearance
Yellow oblong film-coated tablet
Packaging
30 tablets / bottle
Approval status
Active

MFDS item code 202502890 · Approved 2025.11.07 · Insurance code 648105300

Summary

Main use
Treatment of essential hypertension not controlled with amlodipine and valsartan combination therapy
Who takes it
Adults
Adult dose
Take 1 tablet of this drug once daily with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this drug, it is recommended to adjust the dose using the individual components (amlodipine and valsartan as monotherapy or combination therapy). For patients whose blood pressure is not controlled with amlodipine/valsartan combination therapy, administer this drug 5/80/12.5 milligrams and adjust the dose at intervals of at least 2 weeks, taking the patient's blood pressure response into consideration. The maximum dose of this drug is 10/160/25 milligrams. Patients taking amlodipine/valsartan combination therapy together with chlorthalidone as a single agent may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience.

Ingredients

Manufacturer
Kyung Dong Pharm Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with amlodipine and valsartan combination therapy

  • Essential hypertension
View approved original text

This medication is indicated for patients with essential hypertension whose blood pressure is not adequately controlled even with combination therapy of amlodipine and valsartan. Essential hypertension refers to a persistently elevated blood pressure without a specific cause, which can affect heart and vascular health. In such cases, additional treatments or adjustments in medication may be required to manage blood pressure effectively. The therapeutic goal is to reduce blood pressure to within the normal range to minimize the risk of cardiovascular complications. It is essential to work closely with healthcare providers to establish ongoing monitoring and appropriate treatment plans to improve blood pressure control in essential hypertension.

How to take

Adult dose

Take 1 tablet of this drug once daily with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this drug, it is recommended to adjust the dose using the individual components (amlodipine and valsartan as monotherapy or combination therapy). For patients whose blood pressure is not controlled with amlodipine/valsartan combination therapy, administer this drug 5/80/12.5 milligrams and adjust the dose at intervals of at least 2 weeks, taking the patient's blood pressure response into consideration. The maximum dose of this drug is 10/160/25 milligrams. Patients taking amlodipine/valsartan combination therapy together with chlorthalidone as a single agent may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience.

Precautions

This medication may pose a serious risk to the fetus and newborn if taken during pregnancy, particularly in the second and third trimesters; therefore, treatment should be discontinued immediately upon confirmation of pregnancy. Patients with impaired liver function or progressive liver disease should be cautious as electrolyte and fluid balance may be altered, which could result in severe symptoms such as hepatic coma. Patients with severe kidney disease should use this medication cautiously, as one of its components, a diuretic, may strain kidney function, increasing the risk of uremia. Patients who are allergic to any ingredients included in this medication or have certain severe liver or kidney diseases, hypotension, pregnant women, and breastfeeding mothers should avoid its use. Especially, patients with severe hypotension, certain heart valve diseases, shock, anuria, or electrolyte imbalances in the blood should not use this medication. Patients with sodium or fluid depletion must normalize their condition before starting this medication and should seek immediate help if symptoms of hypotension occur during treatment. Patients with elevated serum potassium levels or at risk of hyperkalemia should frequently monitor potassium levels when taking this medication along with potassium supplements. Patients with cardiovascular diseases, such as heart failure, myocardial infarction, kidney transplant patients, and those with acute myocardial infarction should be closely monitored while taking this medication. Side effects such as dizziness, headaches, or decreased blood pressure may occur, so caution is needed when driving or operating machinery. Regular monitoring of liver function, kidney function, and electrolyte levels should be conducted during treatment to check for abnormalities. When combined with other medications, interactions may alter efficacy or increase the risk of side effects; therefore, inform your healthcare provider of any medications you are currently taking. In case of overdose, symptoms such as hypotension, shock, and consciousness disturbances may occur; immediate medical attention should be sought, and blood pressure and heart status should be closely monitored in emergencies. Keep this medication out of reach of children and store it in a sealed container, avoiding moisture, heat, and direct sunlight. This medication is not recommended for children under 18 years of age as its safety and effectiveness have not been established. Elderly patients may be more susceptible to dehydration, hypotension, and electrolyte imbalances, so treatment should be started at a lower dose and closely monitored.

Side effects

Dizziness, headache, increased blood uric acid, increased alanine aminotransferase (ALT), increased aspartate aminotransferase (AST), increased creatine phosphokinase (CPK), increased blood glucose, increased blood triglycerides (TG), COVID-19, nasopharyngitis, upper respiratory tract infection, eyelid twitching, orthostatic hypotension, chest discomfort, flushing, fatigue, edema, palpitations, vertigo, drowsiness, abdominal pain, nausea, weakness, lethargy, pain, weight gain/loss, hypotension, vasculitis, hypertonia, sensory impairment/paralysis, peripheral neuropathy, syncope, taste disorders, tremors, extrapyramidal disorder, erectile dysfunction, gynecomastia, changes in bowel habits, dry mouth, indigestion, gastritis, gingival hyperplasia, pancreatitis, vomiting, hyperglycemia, arthralgia, low back pain, muscle cramps, myalgia, leukopenia, thrombocytopenia, insomnia, mood changes, cough, dyspnea, rhinitis, alopecia, hyperhidrosis, purpura, skin discoloration, urticaria, toxic epidermal necrolysis, tinnitus, visual disturbances, increased frequency of urination, urination disorders, nocturia, hepatitis, jaundice, elevation of liver enzyme levels, indigestion, anemia, tinnitus, hypertonia, decreased motor function, confusion, chest pain, rash, myalgia, edema, weakness, insomnia, erythema, decreased libido, dizziness, viral infection, upper respiratory tract infection, cough, diarrhea, fatigue, rhinitis, sinusitis, abdominal pain, abdominal pain, nausea, pharyngitis, arthralgia, heart failure, arrhythmia, drowsiness, atrial fibrillation, vomiting, constipation, thirst, appetite loss, lethargy, vascular edema, erythema, itching, serum sickness, vasculitis, kidney function impairment, syncope, epistaxis, hepatitis, hypoglycemia, shock, loss of consciousness, rhabdomyolysis, agranulocytosis, vesicular dermatitis, intestinal vascular edema, aplastic anemia, necrotizing vasculitis, pulmonary edema, pancreatitis, agranulocytosis, acute renal failure, hypokalemia, hyperuricemia, increased blood lipids, hyponatremia, hypomagnesemia, hyperglycemia, gout, hypercalcemia, diabetes, deterioration of diabetic metabolic status, hypochloremic metabolic alkalosis, urticaria, skin erythema, photosensitivity reactions, intrahepatic cholestasis, jaundice, orthostatic hypotension, deep vein thrombosis, palpitations, sensory abnormalities, depression, headache, heavy-headedness, appetite loss, gastrointestinal distress, nausea, vomiting, stomach pain, constipation, diarrhea, thrombocytopenia, leukopenia, agranulocytosis, eosinophilia, purpura, visual disturbances, jaundice, erectile dysfunction, pulmonary edema, allergic enteritis, lethargy, muscle weakness, hypotension, tachycardia, hypovolemic shock, consciousness disturbance, coma, muscle elasticity, muscle cramps, sensory abnormalities, drowsiness, hypovolemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture and at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness and prevent degradation.

Appearance and packaging

Appearance

Yellow oblong film-coated tablet

Package unit

30 tablets / bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.